NCCN Task Force Report: Bone Health in Cancer Care. - Wikidata - awgldk - TriplyDB

NCCN Task Force Report: Bone Health in Cancer Care.

NCCN Task Force Report: Bone Health in Cancer Care.

http://www.wikidata.org/entity/Q34617936

about

Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer Implementing the exercise guidelines for cancer survivors Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.Bone mineral density measurements of the proximal femur from routine contrast-enhanced MDCT data sets correlate with dual-energy X-ray absorptiometry.Future of bisphosphonates and denosumab for men with advanced prostate cancer.Status of adjuvant endocrine therapy for breast cancer.Oral health-related complications of breast cancer treatment: assessing dental hygienists' knowledge and professional practice.Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer Management options of breast cancer related osteoporosis.Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals.Patterns of bone density evaluation in a community population treated with aromatase inhibitors.Bisphosphonates: do we know their role in adjuvant breast cancer treatment?Breast cancer survivorship issues.Conducting cancer control and survivorship research via cooperative groups: a report from the American Society of Preventive Oncology.Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor.Breast Cancer: Rank Ligand Inhibition.In-vivo assessment of femoral bone strength using Finite Element Analysis (FEA) based on routine MDCT imaging: a preliminary study on patients with vertebral fractures Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy Mechanisms of cancer cell metastasis to the bone: a multistep process.Treatment Considerations for the Management of Patients With Hormone Receptor-Positive Metastatic Breast Cancer.Periodontal health, perceived oral health, and dental care utilization of breast cancer survivors.Review of functional/anatomical imaging in oncology.Fracture risk in women with breast cancer: a population-based study.Optimizing vitamin D concentrations for breast cancer risk reduction.Assessing the prevalence of compromised bone health among overweight and obese African-American breast cancer survivors: a case-control study.Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab.The management of osteoporosis in breast cancer survivors.The Italian cross-sectional survey of the management of bone metastasis: ZeTa study.Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists.Tumor-targeting Salmonella typhimurium A1-R inhibits human prostate cancer experimental bone metastasis in mouse models.Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors.Bone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines?Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs Eight ways to stay healthy after cancer: an evidence-based message.Long-term Toxicity of Cancer Treatment in Older Patients Senior adult oncology.Breast cancer survivorship symptom management: current perspective and future development.

P2860

Q26824762-8C6875D6-3F62-4F3F-8DDB-ABCBE7BACDAE Q26863685-7BF170A6-B46E-4F68-9DA1-108672D897A1 Q27003664-5CAFDBE6-8C54-4AF0-8746-CEEA015A335F Q28068956-98D8E4A5-D595-4BB4-9565-FC1509479DF0 Q30248756-68791175-7935-4F11-A715-EC347492098A Q30559806-F404AC83-6403-46B1-8109-230ACAB62D67 Q33583525-F9C874D8-4D11-47B4-A872-BFBA5888F489 Q33739138-8D320878-E4CA-49DC-BAE0-039E96D67163 Q33821112-BA051A52-9ED9-4F85-8099-3C85E3347F4E Q34023510-AC31EBA5-2AAC-4F20-8F48-DC4C79581E68 Q34230292-17645895-7D68-427D-B6E8-6CF3A0560A84 Q34266960-89F6CFE7-DCB4-4B84-8B4D-BB29BFB3B66F Q34335213-437EC4D1-5CDC-4DCF-9FFC-8CDBAAC522F8 Q34632094-1EA6BB0C-5B49-44EB-9F11-F8AD0A99B151 Q34895561-B044587F-ECF0-4535-A2C0-57CF3072A0B5 Q35072010-226F2FFC-8206-48B2-AC97-348022F73FB7 Q35095538-E4580DE8-88BE-41EC-95FB-0ED60C146747 Q35095558-D94BD9EB-ACD4-4944-8395-40EFACF4D627 Q35130486-26A7900F-4062-4167-83F7-3A741A3E5E9C Q35206815-BD29264D-BA02-4830-A077-711CB51DAA05 Q35673417-11E1B6CE-3A4F-4C88-BE26-B31CCE2E9030 Q35687540-2A205F52-2F14-49B2-A42C-5D9E3357FEF1 Q35690544-D6C04B9F-E395-48E4-A679-C663E50F32C4 Q35809612-AD2DB76A-7C8C-43D8-BF11-2416254230D5 Q35991921-7549CD9C-41EE-435E-BEF1-E705621C127C Q36009022-35CA6F52-6202-4CDF-AAF1-71D34091D76C Q36105412-A76A9DA1-D104-487D-978A-DE3C22FA9031 Q36187103-53E90635-FA29-4EBA-A951-848C851E76EA Q36405775-8E74AE38-7FED-4F25-8B0C-67E1B2814423 Q36491369-C1133B88-AFA7-4A9E-9447-FC8F68D5CCBB Q36491413-200B4D3A-0E68-4773-B92E-6C2476D72DC9 Q36544572-90D8CBD7-927B-4CF1-9B52-0CADBB023F7D Q36613577-9EB862C2-7407-42D3-B975-FADA0251B489 Q36628819-2918CB18-D7CC-428A-B943-F37CA50F9172 Q36667402-A33D7A5C-CF79-400A-B325-930EB6FE01FD Q36746739-E41CDE65-5951-40A2-859F-437505C8DE1F Q36780465-FFAD54E6-6AA8-43F8-AE2D-8BD81B11B468 Q36821673-88146243-DFAE-4E83-83D7-644B764D5EE5 Q36851424-A22C50E5-F6A9-4542-B94F-C1D20377D1D0 Q36956837-1DB73536-C2F6-4F1C-8DB2-19FF1E9622F4

P2860

NCCN Task Force Report: Bone Health in Cancer Care.

http://www.wikidata.org/entity/Q34617936

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

NCCN Task Force Report: Bone Health in Cancer Care.

@ast

NCCN Task Force Report: Bone Health in Cancer Care.

@en

NCCN Task Force Report: Bone Health in Cancer Care.

@nl

type

label

NCCN Task Force Report: Bone Health in Cancer Care.

@ast

NCCN Task Force Report: Bone Health in Cancer Care.

@en

NCCN Task Force Report: Bone Health in Cancer Care.

@nl

prefLabel

NCCN Task Force Report: Bone Health in Cancer Care.

@ast

NCCN Task Force Report: Bone Health in Cancer Care.

@en

NCCN Task Force Report: Bone Health in Cancer Care.

@nl

P1433

Q34617936-979E1C16-C7E2-4B72-AD4A-931B2284BA63

P1476

Q34617936-6CBD76C4-A41A-4578-B2B4-1C44B25B2AE4

P2093

Q34617936-0F5C8E92-B997-4488-AF7B-7FEE3DC67EE5

Q34617936-2AFC66A7-4408-4C51-AE31-D31A9CCC09A4

Q34617936-3351701D-3E76-4A47-AE02-650DED32B0AB

Q34617936-4E4F6D45-B7C2-4B00-A9A2-475E14469886

Q34617936-56A98761-9037-4B60-9171-1C54397BB5C0

Q34617936-56E4E7B1-E383-45D3-A4C6-2E30CA862A62

Q34617936-5F64BEAB-5A70-4547-9288-1DA12860D28C

Q34617936-81EBDFB9-4A4E-49F3-87D3-D9DFA431FB24

Q34617936-B52C3A50-3CCC-4554-869A-82A5C2CC8379

Q34617936-BA5A5E2B-B33F-4406-839B-878D294F2E06

P2860

Q34617936-00520F59-F3B6-4BAA-9DD2-531216A83502

Q34617936-021280F9-72CC-4F9B-B11F-7764994A80D9

Q34617936-053A3283-9BD4-4181-8103-4912276CDC80

Q34617936-073D0D23-F06B-41C2-A6F7-0651C1EE334A

Q34617936-08D3B3AF-151A-41D4-909A-87A9B7199DDF

Q34617936-0B065F3F-7798-4E73-B437-5FA3D7AAFE26

Q34617936-11007CBB-65DC-42A8-9375-CECDA1766064

Q34617936-11AF155D-CEB4-4591-A601-BA36123C6ADA

Q34617936-1AA7FEB3-289A-415E-A380-DCCCEC9F8818

Q34617936-1E61AD49-18E0-4CA4-952A-CC1A84D4E9EC

P304

Q34617936-0C698C4A-346A-4332-9225-AB3C8831732C

P31

Q34617936-34D86F35-CDF4-42A4-B7FA-A99EED0B2FA8

P356

Q34617936-5C026DEC-D4C9-467A-B4D2-A4FFF9885A39

P478

Q34617936-4A0CF8DC-7254-4828-8456-465630632910

P577

Q34617936-A32A5B7D-F89C-409B-8A31-66D0FF46DD7B

P698

Q34617936-A7569704-5491-47AA-BC46-DE7358CEACEC

P932

Q34617936-B2DE92C9-AB55-4824-A04A-56C53E0AED9F

P356

JNCCN.2009.0076

P1433

Journal of the National Comprehensive Cancer Network

P1476

NCCN Task Force Report: Bone Health in Cancer Care.

@en

P2093

Andrew Shields

http://www.w3.org/2001/XMLSchema#string

Azeez Farooki

http://www.w3.org/2001/XMLSchema#string

Catherine H Van Poznak

http://www.w3.org/2001/XMLSchema#string

Charles L Shapiro

http://www.w3.org/2001/XMLSchema#string

J Sybil Biermann

http://www.w3.org/2001/XMLSchema#string

Julie R Gralow

http://www.w3.org/2001/XMLSchema#string

Matthew R Smith

http://www.w3.org/2001/XMLSchema#string

Monica N Fornier

http://www.w3.org/2001/XMLSchema#string

Rashmi N Kumar

http://www.w3.org/2001/XMLSchema#string

Robert F Gagel

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review.

Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D

Cancer statistics, 2008

Vitamin D deficiency

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis

P304

S1-32; quiz S33-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6004/JNCCN.2009.0076

http://www.w3.org/2001/XMLSchema#string

P478

7 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19555589

http://www.w3.org/2001/XMLSchema#string

P932

3047404

http://www.w3.org/2001/XMLSchema#string